DFG
The large-scale research projects of the Faculty of Medicine Carl Gustav Carus funded by the German Research Foundation are listed below (as at 08.10.2026).
Key Area: Oncological Diseases
- SPP 2084: Colonization and interaction of tumor cells in the bone microenvironment (Spokesperson: Prof. Dr. Lorenz C. Hofbauer, Department of Internal Medicine III)
- Reinhart Koselleck Project: Exploring long-term epigenetic silencing modules to advance the potential of therapeutic gene editing (Prof. Dr. Frank Buchholz, Chair of Systems Biology)
Key Area: Metabolic Diseases
- SFB/TRR 205: The Adrenal Gland: Central Relay in Health and Disease (Spokesperson: Prof. Dr. Dr. Stefan R. Bornstein, Department of Medicine III)
-
SFB/TRR 412 : Metabolic dysfunction-associated steatotic liver disease: From understanding the pathomechanisms to translation into tailored therapy concepts (MASLD) (Spokesperson: Prof. Dr. Frank Tacke, Charité - Universitätsmedizin Berlin, Spokesperson in Dresden: Prof. Dr. Jochen Hampe, Faculty of Medicine Carl Gustav Carus)
- SFB/TRR 369: Inflammation-induced bone degeneration (Dione)
(Spokesperson: Prof. Dr. Aline Bozec, Friedrich Alexander University Erlangen-Nuremberg, Spokesperson in Dresden: Prof. Dr. Martina Rauner, Medical Clinic III) - IRTG 2251: Immunological and cell-based strategies in metabolic diseases (ICSMD) (Spokesperson: Prof. Dr. Stefan R. Bornstein, Department of Medicine III)
- IRTG 3019: Metabolic and endocrinological drivers of susceptibility to infection (MEDIS) (Spokesperson: Prof. Dr. Stefan R. Bornstein, Department of Medicine III)
- FOR 5146: Role of iron metabolism in the osteopathic axis (FerrOs) (Spokesperson: Prof. Dr. Martina Rauner, Department of Medicine III)
- ADAM10: ADAM10 Inhibition to Reduce MI Size by Limiting Neutrophil Invasion in a Large Animal Model with Metabolic Syndrome (Prof. Dr. Ali El-Armouche, Institute of Pharmacology & Toxicology; Prof. Dr. Axel Linke, Dresden Heart Center; Prof. Dr. Peter Markus Spieth, Department of Anesthesiology and Intensive Care Medicine)
Key Area: Neurological & Mental Health Disorders
- SFB/TRR 393: Trajectories of Affective Disorders: Cognitive-Emotional Mechanisms of Symptom Change (Spokesperson: Prof. Dr. Tilo Kircher, Philipps-Universität Marburg, Spokesperson in Dresden: Prof. Dr. Dr. Michael Bauer, Department of Psychiatry and Psychotherapy)
- SFB/TRR 265 – Losing and Regaining Control over Drug Intake (Spokesperson: Prof. Dr. Andreas Heinz, Charité Berlin, Spokesperson in Dresden: Prof. Dr. Michael Smolka, Neuroimaging Center)
- IRTG 2773: Risks and Pathomechanisms of Affective Disorders (Spokesperson: Prof. Dr. Dr. Michael Bauer, Department of Psychiatry and Psychotherapy)
Cluster: Immunology & Inflammation
- SFB/TRR 237: Nucleic Acid Immunity (Spokesperson: Prof. Dr. Min Ae Lee-Kirsch, Department of Pediatrics)
- FOR 5953: Intervening in the Innate Immune Response early after Myocardial Infarction (Spokesperson: Prof. Dr. Ali El-Armouche, Institute of Pharmacology and Toxicology)
Cluster: Medical Data Science & Smart Technologies
- CARE: Sub-project in the Cluster of Excellence "Climate-Neutral and Resource-Efficient Construction" Prof. Michael Gelinsky (1. funding phase)
- CeTi: Sub-projects in the Cluster of Excellence "Centre for Tactile Internet with Human-in-the-Loop" Prof. Tjalf Ziemssen, Prof. Klaus-Dieter Schaser (1. funding phase)
- CeTi²: Sub-projects in the Cluster of Excellence "Centre for Tactile Internet with Human-in-the-Loop" Prof. Jakob Kather, Prof. Martin Wagner (2. funding phase)
- OsmoBank: Development of a Global Research Database for Olfactory and Gustatory Dysfunction (Prof. Dr. Thomas Hummel & Dr. Anna Kristina Hernandez, Department of Otolaryngology)
- REC²: Sub-projects in the Cluster of Excellence "Responsible Electronics in the Climate Change Era" Prof. Ivan Minev (2. funding phase)